Finance18 Apr 2020 16:54
Before cv the sp here was going nowhere with book value of 19.7 ye 2017 drifting to 13.1(e) for 2020 due to falling sales and declining revenues. I am somewhat surprised ODX got a seat at the table based on their financial position, probably a bit of cronyism as much as skill, just my opinion. Iām not surprised to see Omega sell out for clients albeit they started before the MOU, mostly after the interims, they took the out on recent volumes.
One would have expected a lot more financial dd before the MOU. Sure they have a bit of cash having raised Ā£1.6m after expenses in Sept, available from Oct 19 but this was for bau projects and working capital. Ebitda just above water going from .37m to .25m from finals to interims and the last trading update says ebitda will be in line with guidance of .7m. By the skin of their teeth if it does! They have already used 611k of the overdraft, remember they have sold about everything they can, ironically the infectious disease project to NCYT, and now they have a seat at the big table. CD4 has just got away in time but there is a revenue lag, not sufficient to finance bau so whatās the choice. Dip into more credit. Ā£1.3m ish left or take advantage of the higher sp and raise.
The sp may have astronomical potential but at the end of the day the numbers tell a story. There is no finance in the MOU, doesnāt even mention that itās been withheld for commercial reasons. Of course the UK gov will pay, they may have made a down payment but how do you quantity that, it would be hereās a few quid send us the bill later, at best imo. You cannot run a project like 5his on fumes you need the finances to underpin quick decision making.
I see this one as a similar story to GDR, loads of potential but a learning BoD that are kicking the finance can down the road. If you got a story the money is there, look at the accelerated book build from HZD Friday, the placing was announced at 11am and completed at 4pm the same day!
Until the finance pathway is clear this is uninvestable for me or at best a small punt. Remember the mou is for 6 months, a lot can happen in that time and then thereās just the 3 revenue streams to fall back on which really arenāt a hot stock growth story. Once they bit the bullet iāll look in but for now my money is going elsewhere. Gla
Trek